Navigation Links
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
Date:9/5/2012

ies of $203.6 million, which compares with $112.3 million at June 30, 2011. Additionally, the Company had $5.8 million due from Janssen Biotech, Inc. at June 30, 2012 in connection with its cost sharing arrangement. As announced on August 1, 2012 and August 20, 2012, we triggered two milestone payment obligations of $50 million each from Janssen under the collaboration and license agreement. 

"Since partnering with Janssen in December of last year, we have made good progress, clinically and organizationally. As reported, we initiated the first set of Phase III trials for ibrutinib (32765) and continue to broadly and quickly develop this compound across a variety of B-cell malignancies. Importantly, we continue to attract and hire highly competent professionals with excellent track records in the disciplines of science and administration from within the healthcare field. Our Executive Team is pleased with our progress and we thank each of our hard working employees for their dedication and continued commitment to truly make a significant difference for the betterment of healthcare patients in need," said Bob Duggan, Chairman & CEO of Pharmacyclics.

Recent Developments & HighlightsBusiness UpdateDuring the past six months, we have complemented our management team with exceptional managers overseeing key functional areas within the company. This executive team will be capable of building out the organization to complete the development of ibrutinib (PCI-32765) and set up the commercialization structures. The most recent hires and organizational changes are described briefly in this release:

Maky Zanganeh was promoted to Chief Operating Officer. Dr. Zanganeh was hired at Pharmacyclics as Vice President, Business Development in August 2008. Within the first nine months, she established the collaboration with Les Laboratoires Servier, the leading French independent pharmaceutical company, which provided Pharmacyclics immediate up-
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Research and Development Trend Forecast of Pharmaceutical ... offering. Research and Development Trend Forecast ... , 2014-2018 mainly analyzes China,s ... status, supply & demand, competition landscape, and business performance ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... Synthesis Market by Product & Services (Equipment, Reagent, ... Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, ... by MarketsandMarkets, the global Oligonucleotide Synthesis Market is ... $1,070.7 Million in 2014, growing at a CAGR ...
(Date:8/29/2014)... -- ChemImage will present a workshop focused on hyperspectral ... Science Society,s 22 nd International Symposium on ... .  Forensic Scientists will be in attendance ... can bring to examination procedures. ... Development at ChemImage, will host a workshop during ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... FORT LAUDERDALE, Fla., Aug. 20 OmniComm Systems, Inc. ... in the EDC marketplace, today announced that Impax Pharmaceuticals, the ... the TrialMaster EDC solution for conducting a Phase III study ... site clinical trial there can be significant challenges in getting ...
... , MOFFETT FIELD, Calif., Aug. 19 ... for the ancient fusing of two microscopic, single-celled organisms called ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO ) , , By ... a type of single-celled organism without a nucleus -- molecular ...
Cached Medicine Technology:Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinson's Disease 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinson's Disease 3NASA Research Reveals Major Insight Into Evolution of Life on Earth 2
(Date:8/31/2014)... (PRWEB) August 31, 2014 For many, fall ... likely the culprit. Ragweed is the most common cause of ... Americans. , The most common symptoms of ragweed allergy include ... and sneezing. Ragweed allergy can also lead to wheezing, asthma ... should consult an allergist about allergy immunotherapy - the only ...
(Date:8/31/2014)... With years of hard work, Delta has now become one ... the company has updated its wheel loader assortment ... these items are guaranteed to be great. Additionally, they are ... is true that all items in Delta’s used cat ... The firm is making full efforts to help worldwide customers ...
(Date:8/31/2014)... In the wake of growing consumer concerns ... to require mandatory labeling of GMOs on food and ... that affect their own health and the health of ... measures to eliminate GMOs from dietary supplements, NutriGold has ... initiative with the objective of advancing the non-GMO ...
(Date:8/31/2014)... 01, 2014 Top10BestSEOHosting.com, a reliable review ... and announces that FatCow, Arvixe and Hostgator are the ... plenty of ASP.NET hosting companies in the world, but ... complicated to run a reliable ASP.NET server than running ... skills. I firmly believe that FatCow, Arvixe and Hostgator ...
(Date:8/31/2014)... Ticket Down is a dependable source ... at the Sun Life Stadium in early September. Diehard soccer ... game on September 5th between Colombia and Brazil will likely set ... year between Brazil and Honduras at Sun Life Stadium brought in ... and has also been the home of the Florida Marlins of ...
Breaking Medicine News(10 mins):Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 3Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3Health News:Best ASP.NET Hosting Award for August 2014 Released By Top10BestSEOHosting.com 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for September 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for September 5th Match 3
... Whole genome sequencing spelling out a person,s entire ... being a medical option for direct patient care. Physicians ... Genomics Research Institute (TGen) successfully completed sequencing both a single ... of more than 6 billion DNA chemical bases. While ...
... patients were more likely to be readmitted to the hospital ... failure, or pneumonia, according to a new study from Harvard ... higher readmission rates were due to disparities related to both ... "Disparities in health and health care are well-documented in this ...
... Reporter , TUESDAY, Feb. 15 (HealthDay News) -- After ... older black people are more likely to be readmitted ... study finds. Overall, older blacks have 13 percent ... research suggests, while patients treated at hospitals that primarily ...
... two-thirds of California,s 7 million uninsured residents will become eligible ... in 2014, according to a new policy brief from the ... study draws on the latest data from the California Health ... The policy brief, "Two-thirds of California,s 7 Million Uninsured ...
... , TUESDAY, Feb. 15 (HealthDay News) -- Motorcycle helmets reduce ... a widely held belief that the weight of motorcycle helmets ... a popular myth that wearing a helmet while riding a ... Dr. Adil H. Haider, an assistant professor of surgery at ...
... HealthDay Reporter , TUESDAY, Feb. 15 (HealthDay News) ... women and men, with a few small but important differences, ... Each year, 55,000 more U.S. women than men suffer a ... One strong risk factor for stroke is atrial ...
Cached Medicine News:Health News:Whole genome sequencing used to help inform cancer therapy 2Health News:Whole genome sequencing used to help inform cancer therapy 3Health News:Study finds blacks more likely to be readmitted to hospitals after discharge 2Health News:Blacks Readmitted to Hospital More Than Whites: Study 2Health News:Blacks Readmitted to Hospital More Than Whites: Study 3Health News:4.7 million Californians to gain coverage under health reform, new study estimates 2Health News:4.7 million Californians to gain coverage under health reform, new study estimates 3Health News:Motorcycle Helmets Help Protect Against Spine Injury: Study 2Health News:Experts Issue New Heart Disease Guidelines for Women 2Health News:Experts Issue New Heart Disease Guidelines for Women 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: